Make an enquiry
Refer a patient
HCP Logout

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor
Make an enquiry
Refer a patient

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor

Lung

Lung
2025-05-16T00:00:00.000+10:00
Ongoing

CA245-0001

CA245-0001
Non-small cell lung cancer (NSCLC)

Randomized, Double-Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012 + nivolumab FDC) in combination with Carboplatin plus Etoposide vs Atezolizumab in combination with Carboplatin plus Etoposide as First-line Therapy in Extensive-Stage Small Cell Lung Cancer

Randomized, Double-Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012 + nivolumab FDC) in combination with Carboplatin plus Etoposide vs Atezolizumab in combination with Carboplatin plus Etoposide as First-line Therapy in Extensive-Stage Small Cell Lung Cancer

Trial overview

Clinical Area

Medical Oncology

Disease

Non-small cell lung cancer (NSCLC)

Disease site

Lung & bronchus

Study Phase

III

Trial Identifiers

Registration number: NCT06646276

https://clinicaltrials.gov/study/NCT06646276

GenesisCare Location(s)
Principal Investigator(s)
Medical Oncologist

Dr Jessica Smith

B Sci (Hons) MBBS (Hons) MMed, FRACP

Dr Jessica Smith
location pin icon

Campbelltown (Oncology)

View Profile
Profile Image - Dr Jessica Smith

Clinical trials enquiries

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.


 

Disclaimer:

This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.